News

A team of scientists led by chemists Stephen Martin and James Sahn at The University of Texas at Austin have discovered what they say is a powerful pain reliever that acts on a previously unknown pain pathway. The synthetic compound, known as UKH-1114, is as effective at relieving neuropathic pain in injured mice as a drug widely used for pain relief called gabapentin, but it works at a much lower dose, with longer duration of action.

About a third of all deaths in the U.S. could be prevented or substantially delayed by organ transplantation, according to a 2015 report from the U.S. military. The main bottleneck is that there is no practical way to preserve organs for more than a few hours. If you try to freeze a whole organ, water within and between cells forms ice crystals that cause the cells to rupture.

Gerhard Fonken, former executive vice president and provost at The University of Texas at Austin, died this month at the age of 88. Fonken served the university for more than 35 years in various research, teaching and administrative roles, including professor in the Department of Chemistry and vice president of academic affairs and research.

Chemists at The University of Texas at Austin have developed a material that holds the key to cheap, fast and portable new sensors for a wide range of chemicals that right now cost government and industries large sums to detect. The innovation could lead to major public health gains, as it holds the potential to drastically reduce the costs associated with cleaning-up accidental chemical spills, remediating old industrial sites, detecting radioactive contamination in drinking water, and operating medical and research imaging devices.

Stephen Martin, a professor of chemistry at The Univeristy of Texas at Austin, has garnered the American Chemical Society's Ernest Guenther Award in the Chemistry of Natural Products for a career of outstanding work in that area.

Assistant professor of chemistry Livia Eberlin sat down with The Texas Scientist to discuss her work.

Sean Roberts, an assistant professor in the Department of Chemistry at The University of Texas at Austin, has received the Faculty Early Career Development (CAREER) Award from the National Science Foundation to pursue his research on the electrical properties of the surfaces of thin materials, which has long-range potential to inspire more energy efficient solar cells, lighting and electronic displays. The award will also support an outreach program designed to give community college students hands-on experience with research.

Ryan Pekarek, a fourth-year doctoral candidate in the Department of Chemistry, has two passions: renewable energy and science education. Luckily he's found a way to pursue both on the Forty Acres through his involvement in H2fromH20, an outreach program started by Michael Rose, assistant professor in the Department of Chemistry.

The Cancer Prevention & Research Institute of Texas (CPRIT) awarded an Early Translational Research grant to chemist Livia Eberlin, for the development of a new tool to accurately recognize thyroid cancer. The new tool, utilizing a technology called ambient ionization mass spectrometry, looks for patterns in the abundance of metabolites, or end products of biological processes, to rapidly determine whether cancer is present in a sample.

Professor of chemistry Jonathan Sessler has been named the 2016 UT Inventor of the Year for his prodigious work that contributed to groundbreaking new pharmaceuticals to fight cancer and a successful company, sold last year for billions of dollars.

Livia Eberlin of The University of Texas at Austin is one of five leading female scientists chosen to receive a 2017 Marion Milligan Mason Award for Women in the Chemical Sciences from the American Association for the Advancement of Science (AAAS).

This fall marks the 15^th anniversary of the U.S. anthrax letter attacks that sickened dozens of people and killed five. At the time, there was no effective treatment for a late stage infection. The attacks accelerated work already underway at the University of Texas at Austin. Brent Iverson, George Georgiou and Jennifer Maynard borrowed a page from Mother Nature's playbook to develop the world's first treatment for late stage inhalation anthrax.

Alzheimer's disease, the sixth leading cause of death in the United States, has proven especially thorny for researchers: no cure has been found, nor has there been any treatment proven to slow the progression of the disease once it sets in. In a new study published in the Proceedings of the National Academy of Sciences, scientists have taken a back-to-the-beginning approach, examining what happens at the start of a chain reaction that occurs before onset of the disease.

Researchers at The University of Texas at Austin have invented a new flexible smart window material that, when incorporated into windows, sunroofs, or even curved glass surfaces, will have the ability to control both heat and light from the sun. Their article about the new material will be published in the September issue of Nature Materials.

Scientists at The University of Texas at Austin have developed a new method to rapidly detect a single virus in urine, as reported this week in the journal Proceedings of the National Academy of Sciences.